Form 4 holding
SVP and Chief Business Officer, Director
Adamis Pharmaceuticals Corp
- Security class
- Common Stock
- Shares / value
- 233,906
- Estimated value
- $141,186
- Report date
- 18 Mar 2022
- Price
- $0.6036
- Ownership
- Direct